MBX · MBX Biosciences, Inc. Common Stock

Summary

MBX Biosciences, Inc. furnished its results of operations under Item 2.02 via Exhibit 99.1 press release dated March 12, 2026. This disclosure provides key financial metrics relevant to investor assessment of the company's performance.

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02 - Results of Operations furnished
• Exhibit 99.1 - Press Release issued on 2026-03-12
• Item 9.01 references financial statements and exhibits